case_images: PMC5011224_01
case_images: Clinical course of our case. Induction therapy consisted of cyclophosphamide 1,200 mg/m2 on day 1, doxorubicine 60 mg/m2 on days 1-3, vincristine 1.3 mg/m2 on days 1, 8, 15, and 22, L-asparaginase 3,000 U/m2 on days 9, 11, 13, 16, 18, and 20, and prednisolone 60 mg/m2 on days 1-21. DRPM, doripenem; VCM, vancomycin; PIPC/TAZ, piperacillin-tazobactam; GM, gentamicin; and LVFX, levofloxacin.
case_images: CRIHEM2016-7648628.001.jpg
case_images: PMC5011224_01_CRIHEM2016-7648628.001.jpg
case_images: fig1
case_images: TdT. Cytogenetic analysis showed a complex karyotype without t(9; 22). The patient was diagnosed with precursor-B ALL and received induction chemotherapy comprising cyclophosphamide, doxorubicin, vincristine, L-asparaginase, and prednisolone (Figure 1).